Method for vacuum ultrasound extraction of bioactive propolis compounds
FIELD: medicine.
SUBSTANCE: raw material is grinded that is followed with vacuum ultrasonic extraction with 80% ethyl alcohol at 18-20°C.
EFFECT: invention allows simplifying the process and improving product purity.
1 ex
The invention relates to medicine and relates to a method of allocation of propolis raw biological groups and labile compounds used as a drug of the drug, "Propolis tincture 10% concentration in the alcohol solution of 80% concentration, with a shelf life of three years and improvement in all indicators, introduced in Pharmacological article, thereby reducing the recovery process and improve the quality of propolis raw stabilize all physico-chemical and technological properties of the substance, alcoholic propolis.
In order to improve the quality of propolis tincture and enhance the yield of biologically active compounds from the depths of pieces of propolis raw to 100% extraction we have developed a vacuum-ultrasonic technology of extraction of biologically active compounds at low temperature (18-20°C), which ensures the safety of all labile components and prevents the passage of the solvent, the associated inactive substances (waxes) and other compounds, due to the high purity of the end of extraction process that ensures the stability of all readings monograph "Propolis tincture".
As a prototype of the proposed positive solution Method to obtain propolis extract alcohol (EN 2073519 - (5). Nedostreljannaja vacuum extraction of propolis raw is the constant evaporation under vacuum 96% ethanol feed vapors in the cooling device, that leads to considerable loss of cooling water and the loss of ethanol 2-5%if you use a closed cycle, it will be a great loss of energy consumption for cooling water, 3-4 cycle evaporation of ethanol 96% and return it to wyborny cube, i.e. in the reactor. Extractable substances that remain in the evaporator Cuba, when re-filling the cube precipitate will be dissolved, what is undesirable after each cycle, so the remains must be constantly removed from the intermediate tank, which is time consuming and leads to great cost of time. The proposed vacuum extraction is not aimed at the creation of dosage forms of propolis tincture, it gives evaporation to a dry residue, such vacuum technology does not take into account the percentage of propolis raw, so you cannot calculate propolis tincture containing 10% propolis raw content of polyphenols, flavonoids, phenolic hydroxyl groups, heavy metals, microbial limits, antimicrobial activity under Pharmacopoeial article of the Ministry of health and social development.
Shown in the patent table reflect the degree of extraction of solids from propolis raw 96% ethanol at 45°With vacuum method, one stripped off to the dry residue. Extraction of 96% ethyl alcohol reduces the output of propol the sa-raw water-soluble biologically active substances. The precipitate vacuum method is used only for animals that are reflected in the technical specifications, in particular, for trudnozazivate RAS surface layers of the skin of animals, but not in medicine.
In the proposed patent the aim of the invention is the elimination of all the above drawbacks. For this purpose we have developed a vacuum-ultrasonic extraction the extraction of biologically active compounds from propolis raw 80% ethanol, at low temperatures (16-20°C), while increasing the degree of extraction of extractive substances from the depths of pieces of propolis raw, vacuum-ultrasonic device leads to the fact that propolis raw loses flexibility and becomes brittle, it disappears high adhesion.
Vacuum ultrasound allows to obtain fine particles of propolis raw, in alcohol, which leads to high extraction of biologically active substances. Therefore, the extraction is carried out at low temperature, which ensures the safety of all labile components and prevents the passage in the extract associated, undesirable substances (wax) and other compounds, which results in high purity of the final product, i.e. propolis tincture.
Example 1.
For this frozen propolis raw crushed in the crushing plant. Crushed in the crushing set is VCE propolis - raw is placed in purified water, mix thoroughly and leave to stand for 10-15 minutes. Pop-up on the surface of the water particles of wax and other impurities are removed, deposited on the bottom of the tank particles propolis raw collected on a stainless steel sieve and dried at room temperature 20-25°C during the day. Weigh the dried propolis raw and loaded into a glass column No. 1, diameter 0, 2 m, height 1 m from the filter at the bottom of the device. In column No. 1 load 10 kg of propolis raw in another tank or column prepared 80% ethanol 90 HP In a glass column No. 1 set ultrasonic device in the middle of crushed propolis raw and plug it in the electrical network of an alternating current. Use the power vacuum ultrasonic installation is negligibly small, only 5 volts, and the weight is only 200,
Column No. 1 sealed to the upper edge of the column attach the vacuum hose connected to the vacuum membrane pump and tank, where prepared with ethanol 80% ethanol for 10% of the content of propolis in alcohol solution. In column No. 1, in the upper part is the gauge, which will control the negative pressure in the column No. 1.
Start the extraction carried out in the following way: cover the bottom of the faucet in the column No. 1 include vacuum membrane the ASAS and when the vacuum reaches 0,65-0,75 MPa in column No. 1, manually control the flow of 80% ethanol, so that the pressure did not fall below 0.6 MPa. When the column No. 1 is filled with ethyl alcohol 80% in the amount of 30 liters, the lower the crane column is closed when the vacuum reaches 0,65-0,75 MPa, the upper crane column No. 1 block, include a vacuum membrane pump, in the fall of rarefaction periodically include a vacuum pump.
The first vacuum-ultrasonic extraction is carried out in the column No. 1 for 3 hours, at a content of 80% ethanol in the amount of 30 l after 3 hours, turn off the vacuum and lower the crane switch in the tank for collecting propolis tincture and under the pressure of the extract is filtered and flows into the collection vessel of the extractant. After removal of the extract column No. 1 again fill 80% ethyl alcohol, as in the beginning of the process, in the amount of 30 l and perform the same process, but stand for 1.5 hours, this is the second extraction of the same raw propolis.
A third extraction of propolis raw in column No. 1 is carried out, as the previous one, but stand one hour, only to have full use of the prepared 80% ethanol for 10 kg of propolis raw.
Thus, the proposed vacuum altasnova extraction of propolis raw is more effective in obtaining EC the paths of propolis alcohol and technologically has a number of advantages in comparison with known methods. Improve all indicators of the quality control of propolis tincture included in the Pharmacopoeia article, and meet all the standards prescribed by the specification "Propolis tincture".
The method of producing propolis extract alcohol by crushing raw materials, extraction with ethyl alcohol under vacuum followed by filtration, characterized in that the extraction of 80%ethyl alcohol spend vacuum-ultrasonic method at 18-20°C.
FIELD: chemistry.
SUBSTANCE: invention relates to household chemistry, medicine, cosmetic-fragrance industry. Material is extracted using aqueous propyleneglycol extracting agent in a rotor-pulse apparatus without presoaking in continuous circulation mode with ratio of plant material to extraction agent ranging from 1:10 to 1:20 and rotor speed of 3600 to 4400 rpm for 5 to 15 minutes at 25 to 55°C with subsequent filtering off the solid plant part. 1,2-propyleneglycol with water content ranging from 0.1 to 95 wt % is used.
EFFECT: invention allows for cutting on extraction time and obtaining extract with high content of flavonoids (by 20 to 40%) and high resistance to microbiological pollution.
2 cl, 3 tbl, 20 ex
FIELD: chemistry.
SUBSTANCE: invention relates to the chemical and pharmaceutical industry. Schizandra seeds are extracted using 70-90% ethyl alcohol first at room temperature and then while heating at temperature between 65-70°C.
EFFECT: invention increases output of active substances.
2 ex, 1 tbl, 1 dwg
FIELD: wood working industry.
SUBSTANCE: invention relates to wood chemical industry. Waste wood of aspen is chopped till particle size is less than 1 mm, is dried on air till moisture content is not more than 18%, raw material is watered at a temperature of 18-25°C with the following ratio of the raw material: extractant = 1:1.5-2.5, within 10-24 hours, further mechanical pressing of extractant and concentrating it in a vacuum at a temperature of not higher than 40°C till content of total solids is from 3.5 to 100%.
EFFECT: invention allows fulfilling the specified purpose.
10 ex, 3 tbl
FIELD: medicine.
SUBSTANCE: method for making cream-gel of celandine extract includes selection of fresh blooming and fruit ripening plants, then milled to vegetation debris, put into an opaque container with glass walls and kept under certain conditions. During this period, fogging-off plants are irrigated once or twice with a standard end extract from previous collections. Then the whole debris is filled in with boiled water and further fermented (liquid phase) to eliminate smell. Liquid is separated from vegetation debris, spilled in an ajar glass, kept under certain conditions, at first filtered through the usual filter, and then through the ultrafilter membrane, added to a liquid crystal cream-gel base.
EFFECT: cream-gel of celandine extract with effective therapeutic action.
2 cl, 1 ex
FIELD: food industry.
SUBSTANCE: invention relates to technology of manufacturing coffee substitute. Method provides for extraction of allspice by liquid nitrogen with corresponding miscella separation, preparation of girasol, its cutting, drying in microwave field during at least one hour till residual humidity not less than 20% at microwave filed power providing temperature inside the bits up to 80-90°C, frying, impregnation of separated miscella providing pressure boost, depressurisation till atmosphere pressure with girasol freezing and its cryomilling in medium of exuded nitrogen.
EFFECT: method provides for production of coffee drink according to nonwaste technology.
FIELD: food products.
SUBSTANCE: method provides for extraction of red tea by liquid nitrogen with corresponding miscella separation, preparation of girasol, its cutting, drying in microwave field during at least one hour till residual humidity not less than 20% at microwave filed power providing temperature inside the bits 80-90°C, frying, impregnation of separated miscella providing pressure boost, depressurisation till atmosphere pressure with girasol freezing and its cryomilling in medium of exuded nitrogen.
EFFECT: production of coffee drink according to nonwaste technology.
FIELD: food products.
SUBSTANCE: method provides for extraction of jeera by liquid nitrogen with corresponding miscella separation, preparation of girasol, its cutting, drying in microwave field during at least one hour till residual humidity 20% at microwave filed power providing temperature inside the bits 80-90°C, frying, impregnation of separated miscella providing pressure boost, depressurisation till atmosphere pressure with girasol freezing and its cryomilling in medium of exuded nitrogen.
EFFECT: production of coffee drink according to nonwaste technology.
FIELD: food products.
SUBSTANCE: method provides for extraction of cardamom by liquid nitrogen with corresponding miscella separation, preparation of girasol, its cutting, drying in microwave field during at least one hour till residual humidity 20% at microwave filed power providing temperature inside the bits 80-90°C, frying, impregnation of separated miscella providing pressure boost, depressurisation till atmosphere pressure with girasol freezing and its cryomilling in medium of exuded nitrogen.
EFFECT: production of coffee drink according to nonwaste technology.
FIELD: food products.
SUBSTANCE: method provides for extraction of tangerine peels by liquid nitrogen with corresponding miscella separation, preparation of girasol, its cutting, drying in microwave field during at least one hour till residual humidity not less than 20% at microwave filed power providing temperature inside the bits 80-90°C, frying, impregnation of separated miscella providing pressure boost, depressurisation till atmosphere pressure with girasol freezing and its cryomilling in medium of exuded nitrogen.
EFFECT: production of coffee drink according to nonwaste technology.
FIELD: food products.
SUBSTANCE: method provides for extraction of dill seeds by liquid nitrogen with corresponding miscella separation, preparation of girasol, its cutting, drying in microwave field during at least one hour till residual humidity 20% at microwave filed power providing temperature inside the bits 80-90°C, frying, impregnation of separated miscella providing pressure boost, depressurisation till atmosphere pressure with girasol freezing and its cryomilling in medium of exuded nitrogen.
EFFECT: production of coffee drink according to nonwaste technology.
FIELD: veterinary science.
SUBSTANCE: invention concerns veterinary pharmacology, particularly products intended for treatment of mastopathies in female farm animals. As active ingredients, a medical product contains dense fraction of dry stock of hazel and dimethyl sulphoxide sublimation; and as an excipient it contains high-molecular polyethylene glycol-1500 in the following relation (wt %): dense fraction of dry stock of hazel - 9.5…10.5; dimethyl sulphoxide - 9.5…10.5; the excipient - the rest. The medical product arrests course of inflammatory process and possesses bactericidal, fungicidal, antiinflammatory and local anaesthetic action.
EFFECT: invention provides higher therapeutic efficiency in treatment of mastopathies in female farm animals.
FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, to obtaining compounds, to be exact, having an effect of angiogenesis inhibitors and can be used in medicine to treat the diseases accompanied by unbalanced vascularisation. The resulting fused protein consists of angiostanin and endostanin or biologically active fragments of angiostanin and endostanin covalently bonded with each other as well as with a sequence of aminoacids (Arg-Gly-Asp)n, where n=1-3 located on C- and/or N-end of the polypeptide chain and/or between sequences of angiostanin and endostanin and/or their fragments.
EFFECT: invention enables to obtain fused protein having an effect of angiogenesis inhibitors and with a high therapeutic effectiveness and a low level of side effects.
2 dwg, 3 tbl, 3 ex
FIELD: chemistry.
SUBSTANCE: invention relates to a salt of amine with carbostyril derivative, formed from carbostyril derivative, with formula , R is a halogen atom, substitution position in the side chain is the 3rd or 4th position in the carbostyril skeleton, and the bond between the 3rd and 4th positions on the carbostyril skeleton is a single or double bond, and amine, chosen from: amino acid; C1-6alkyl-substituted amine, which can have a substituted chosen from a group which contains a hydroxy group and an amino group; and amino sugar, which dissolves in water very well. The invention also relates to a pharmaceutical composition which contains a salt of amine with carbostyril derivative of formula (I) as an active ingredient.
EFFECT: new salts are obtained, with useful biological properties.
25 cl, 13 ex
FIELD: chemistry.
SUBSTANCE: formula compound is described, where X is oxygen; R1 is a linear or branched C1-C8-alkyl chain, substituted with phenyl, optionally substituted with halogen atoms; R2, R3 independently represent hydrogen, C1-C3-alkyl chain, halogen, methoxy; R4, R5, R6, R7 independently represent hydrogen, as well as a method of obtaining formula (I) compound, and a pharmaceutical composition.
EFFECT: use of the compound to make a medicinal agent which is effective as a modulator of the sodium and/or calcium channel and, consequently, suitable for preventing, relieving and treating a wide range of pathologies which include neurological, psychiatric, cardiovascular, phlogistic, eye, urological, metabolic and intestinal diseases, where the above mentioned mechanisms are described as playing a pathological role.
6 cl, 11 ex
FIELD: medicine.
SUBSTANCE: invention concerns chemical and pharmaceutical industry, particularly production of natural media with anti-inflammatory and anti-microbe effect. Mixture includes European pyrola, sidebells wintergreen and prairieweed at 2:2:6 ratio.
EFFECT: enhanced efficiency of treatment, reduced inflammatory changes, reduced duration and intensity of painful sensations, extended range of herbal medicines.
FIELD: pharmacology.
SUBSTANCE: invention concerns compounds of formula (I) , where A is optionally substituted monocyclic aryl and heteroaryl group, B is optionally substituted monocyclic nitrogen-containing heterocyclic group, and either a) R1 is hydrogen atom and R2 is group selected out of -NH2 and optionally substituted alkinyl group, or b) R2, R1 and -NH- group with linked R1 form fragment selected out of fragments of formulae
,
,
and
, where Ra is selected out of hydrogen atom and group selected out of optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted aryl, -OR3, where R3 is independently selected out of group including hydrogen atom and lower alkyl or cycloalkyl groups, Rb is selected out of hydrogen atom and group selected out of optionally substituted alkyl or optionally substituted cycloalkyl group; application of claimed compounds in medicine obtainment for treatment of pathological states or diseases, the course of which is alleviated by antagonistic effect on adenosine receptor A2B, and pharmaceutical composition with antagonistic effect on adenosine receptor A2B.
EFFECT: compounds applicable in treatment of such diseases as asthma, bronchostenosis, allergic diseases, hypertension, atherosclerosis, reperfusion injury, myocardial ischemia, retinopathy, inflammation, gastrointestinal disorders related to cell proliferation, diabetes and/or autoimmune diseases.
26 cl, 49 ex, 2 tbl
FIELD: pharmacology.
SUBSTANCE: invention concerns novel compounds of formula (1a) or (1b) or their pharmaceutically acceptable salts with inhibition effect on matrix metalloproteinases (MMP). In formula
or
T is absent; G1 and G2 is independently CH or N; A is C1-6alkyl; B is a link; D is a link; E is phenyl substituted by condensed heterocyclic ring in the form of nitrogen-containing ring which can be substituted by carbonyl groups; or substituted 6-membered heteroaryl or bicyclic heteroaryl where second ring in bicyclic system is benzene ring, and heteroaryl is 5-6-membered ring containing 1, 2 or 3 nitrogen heteroatoms, and heteroaryl is substituted by 1, 2 and 3 groups selected out of oxo and C1-6alkyl-; R16 is C1-6alkyl; R18 is halogeno, cyano, nitro, OR16 , OCF3, SR16 or COR16; m is 0 or integer 1 or 2; n is 0.
EFFECT: obtaining compounds and pharmaceutical composition based on them.
13 cl, 18 ex
FIELD: medicine.
SUBSTANCE: ointment contains ospen rind powder, fumitory herbs, flaxweed flowers, greater celandine leaves, cotton burdock leaves, roots and rootstocks of elecampane inula, licopid, lanolin and hog fat upon specified component ratio. The use of the ointment ensures immunomodulating anti-inflammatory and reparative activity.
EFFECT: fast wound repair.
2 ex
FIELD: medicine.
SUBSTANCE: there obtained is analgetic remedy owing to the structure of APHCl polypeptide having the following amino-acid sequence: H2N-Gly1-Ser2-lle3-Cys4-Leu5-Glu6-Pro7-Lys8-Va19-Val10-Gly11-Pro12-Cys13-Thr14-Ala15-Tyr16-Phe17-Arg18-Arg19-Phe20-Tyr21-Phe22-Asp23-Ser24-Glu25-Thr26-Gly27-Lys28-Cys29-Thr30-Val31-Phe32-lle33-Tyr34-Gly35-Gly36-Cys37-Gly38-Gly39-Asn40-Gly41-ASn42-Asn43-Phe44-Glu45-Thr46-Leu47-Arg48-Ala49-Cys50-Arg51-Ala52-lle53-Cys54-Arg55-Ala56-COOH.
EFFECT: effective anodyne of new generation, which has directed action on cellular target.
8 dwg, 1 tbl, 10 ex
FIELD: chemistry.
SUBSTANCE: described is a new uniformly tritium-labeled 4,4-fluoro-N-{(1S)-3-[3-(3-isopropyl-5-methyl-4H-1,2,4-trizol-4-yl)-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl}cyclohexane carboiimide (maraviroc) of formula I .
EFFECT: said compound can be used in analysis of physiologically active compound-analogue.
1 cl, 1 ex, 2 dwg
FIELD: medicine.
SUBSTANCE: invention refers to pharmaceutical industry, particularly to agents for treating wounds, ulcers and decubitus ulcers. A balsamic liniment for treating wounds, ulcers and decubitus ulcers is based on sapropel tar, xeroform, aerosil, sapropel oil taken in a certain relation.
EFFECT: liniment described above shows improved clinical effectiveness in relation to wounds, ulcers and decubitus ulcers.
7 tbl, 1 ex
